Changeflow GovPing Pharma & Drug Safety EPO Patent Grant EP3774875B1: Surfactant Protei...
Routine Notice Added Final

EPO Patent Grant EP3774875B1: Surfactant Protein D Compositions

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has granted patent EP3774875B1 for "Methods and Compositions Comprising Surfactant Protein D (SP-D)". The patent was granted on March 18, 2026, and covers various applications and compositions related to SP-D.

What changed

The European Patent Office (EPO) has granted patent EP3774875B1, titled "Methods and Compositions Comprising Surfactant Protein D (SP-D)". This grant signifies the official recognition of intellectual property rights for the patented inventions related to SP-D compositions and their methods of use. The patent lists Jan Susan Rosenbaum and others as inventors and includes various IPC classifications related to pharmaceutical compositions and biotechnology.

This patent grant is primarily an intellectual property event and does not impose new regulatory obligations on companies. However, it may affect companies operating in the biotechnology and pharmaceutical sectors by potentially restricting the use of the patented technology without licensing. Companies involved in the development or commercialization of SP-D compositions should review the patent details to ensure compliance with intellectual property rights and to identify potential licensing opportunities or restrictions.

Source document (simplified)

← EPO Patent Bulletin

METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D)

Grant EP3774875B1 Kind: B1 Mar 18, 2026

Inventors

ROSENBAUM, Jan Susan, MANNING, Mark Cornell, KATAYAMA, Derrick S., PAULETTI, Giovanni M., GRANT, Shawn, HOLCOMB, Ryan

IPC Classifications

A61K 9/19 20060101AFI20251021BHEP A61K 9/00 20060101ALI20251021BHEP A61K 47/02 20060101ALI20251021BHEP A61K 47/18 20170101ALI20251021BHEP A61K 47/26 20060101ALI20251021BHEP A61P 11/00 20060101ALI20251021BHEP C07K 14/785 20060101ALI20251021BHEP A61K 38/00 20060101ALI20251021BHEP C12N 5/09 20100101ALI20251021BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D)

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3774875B1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Labeling
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Intellectual Property Biotechnology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.